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mortalityDear Editor,
I have serious misgivings about the reliability of the data
produced by Watson and colleagues1 supposedly character-
ising factors associated with asthma mortality following
hospital admission.
These data used for the study; CHKS data (essentially
hospital episode statistics [HES data]), do not contain
sufficient detail to investigate the study question. Impor-
tantly, these data can only report in-hospital deaths and not
deaths immediately following hospital discharge which may
have been a consequence of the hospital admission. Nor was
it possible to track patients who may have been transferred
for specialist hospital services who had then died. Thus the
descriptive epidemiology provided is of limited value. Due
to a lack of relevant data, this asthma-related study
excluded important and meaningful parameters, such as
treatment medications, spirometry or some other measure
of asthma severity, duration of illness, smoking status,
cardiovascular disease risk and so on.
Regarding their statistical analysis, even if data of
sufficient depth and quality were available to the investi-
gators, multivariate modelling techniques are required to
determine the independent impact of any specific factor in
increasing the risk of death. Simply finding that whenont matter & 2007 Elsevier Ltd. All rights reserved.
2007.07.026patients’ have multiple co-existing diseases recorded
simultaneously while being admitted to hospital i.e.,
increased medical morbidity, they have a corresponding
increase in the likelihood of hospital admission or the risk of
death is uninformative.
The question investigated in the above study is an
important one but, in general, CHKS data should be avoided
when characterising the epidemiology of mortality and
factors that may alter the risk of death. The General
Practice Research Database (GPRD)2 is likely to soon contain
data from 7% of the UK population that will include GP
contacts, primary care diagnoses, biochemistry, risk factor
data and prescribed medications in addition to linked
hospital admissions (HES data) and comprehensive mortality
data from the Office of National Statistics (ONS). This will
provide a much more informative and appropriate source of
data in the United Kingdom for studies of this type.
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